Wednesday, March 11th, 2009
The fallout from the Supreme Court's Wyeth v. Levine decision will be added burden not just for pharmaceutical manufacturers, but FDA as well, according to Gary Liberson and Craig Wylie in PA Consulting's Life Sciences & Healthcare practice. Pharmaceutical marketers will be burdened to meet individual State product care laws. ...
Posted in
Sales & Marketing |
No Comments »
Wednesday, March 4th, 2009
With the pharmaceutical industry's effort to enshrine federal FDA pre-emption in the laws of the land taking a tumble after today's Supreme Court ruling in Wyeth v. Levine, mass torts plaintiffs attorneys everywhere are licking their lips. We asked Will Sachse, a partner in the antitrust/competition and mass torts and ...
Posted in
Legal actions |
2 Comments »
Wednesday, March 4th, 2009
The pre-emption question has been answered. But it wasn't what Wyeth or the rest of the pharma industry wanted to hear.
As part of our Agenda 2009 report in January, we reported on the U.S. Supreme Court case Wyeth v. Levine, which asked the judges to decide whether federal regulations governing ...
Posted in
Legal actions, Sales & Marketing |
1 Comment »
|
|
